Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21(WAF1/CIP1)

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 837-842

  Sato, Norihiro ^a   Mizumoto, Kazuhiro ^a   Maehara, Naoki ^a   Kusumoto, Masahiro ^a   Nishio, Shoko ^a   Urashima, Taro ^a   Ogawa, Takahiro ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antisense oligodeoxynucleotide; Apoptosis; Cisplatin; Mdm2; Mitomycin C; P21(WAF1 CIP1)

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC METAL COMPLEX; ANTISENSE OLIGODEOXYNUCLEOTIDE; CISPLATIN; MESSENGER RNA; MITOMYCIN C; PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; DNA DAMAGE; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BONE NEOPLASMS; CELL SURVIVAL; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; MITOMYCIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034097572     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
2. Levine AJ: p53 the cellular gatekeener for growth and division. Cell 88: 323-331, 1997.
3. Harris CC: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455, 1996.
4. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
5. Fakharzadeh SS, Trusko SP and George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10: 1565-1569, 1991.
6. Momand J, Zambetti GP, Olson DC, George D and Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245, 1992.
7. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B: Oncoprotein Mdm2 conceals the activation domain of tumour suppressor p53. Nature 362: 857-860, 1993.
8. Haupt Y, Maya R, Kazaz A and Oren M: Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299, 1997.
9. Kubbutat MHG, Jones SN and Vousden KH: Regulation of p53 stability hy Mdm2. Nature 387: 299-303, 1997.
10. Wu X, Bayle JH, Olson D and Levine AJ: The p53-Mdm-2 autoregulatory feedback loop. Genes Dev 7: 1126-1132, 1993.
11. Landers JE, Cassel SL and George DL: Translational enhancement of Mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res 57: 3562-3568, 1997.
12. Momand J, Jung D, Wilczynski S and Niland J: The Mdm2 gene amplification database. Nucleic Acids Res 26: 3453-3459, 1998.
13. Quesnel B, Preudhomme C, Oscier D, Lepelley P, Collyn-d'Hooghe M, Facon T, Zandecki M and Fenaux P: Over-expression of the Mdm2 gene is found in some cases of haematological malignancies. Br J Haematol 88: 415-418, 1994.
14. Suzuki A, Toi M, Yamamoto Y, Saji S, Muta M and Tominaga T: Role of Mdm2 overexpression in doxorubicin resistance of breast carcinoma. Jpn J Cancer Res 89: 221-227, 1998.
15. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1. a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
16. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
17. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D: p21, is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
18. WAF1. Cancer Res 55: 4536-4539, 1995.
19. Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werbel B and Barnett GH: WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 13: 1279-1285, 1996.
20. waf1/cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 18: 2789-2797, 1999.
21. Polyak K, Waldman T, He TC, Kinzler KW and Vogelstein B: Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10: 1945-1952, 1996.
22. WAF1/Cip1 protects against p53-mediated apoptosis of human melanoma cells. Oncogeny 14: 929-935, 1997.
23. Gomez-Manzano C, Fuevo J, Kvritsis AP, McDonnell TJ, Steck PA, Levin VA and Yung WK: Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst 89: 1036-104, 1997.
24. Bissonnette N and Hunting DJ: p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 16: 3461-3469, 1998.
25. Wang Y, Blandino G and Givol D: Induced p21waf1 expression in HI299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene 18: 2643-2649, 1999.
26. Chen L, Agrawal S, Zhou W, Zhang R and Chen J: Synergistic activation of p53 by inhibition of Mdm2 expression and DNA damage. Proc Natl Acad Sci USA 95: 195-200, 1998.
27. Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK and Barna BP: Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J 12: 801-811, 1998.
28. Sato N, Mizumoto K, Kusumoto M, Niiyama H, Maehara N, Ogawa T and Tanaka M: 9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells. FEBS Lett 441: 318-321, 1998.
29. Zhang L, Mizumoto K, Sato N, Ogawa T, Kusumoto M, Niiyama H and Tanaka M: Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin. Cancer Lett 142: 129-137, 1999.
30. Baertschi AJ: Antisense oligonucleotide strategies in physiology. Mol Cell Endocrinol 101: 15-24, 1994.
31. Duncan VE, Ajmani PS and Hughes JA: Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity. Anticancer Res 18: 4105-4108, 1998.
32. Flanagan WM and Wagner RW: Potent and selective gene inhibition using antisense oligodeoxynucleotides. Mol Cell Biochem 172: 213-225, 1997.
33. Lappalainen K, Urtti A, Soderling E, Jaaskelainen I, Syrjanen K and Syrjanen S: Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells. Biochim Biophys Acta 1196: 201-208, 1994.
34. Storey A, Oates D, Banks L, Crawford L and Crook T: Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Nucleic Acids Res 19: 4109-4114, 1991.
35. Perez JR, Li Y, Stein CA, Majumder S, Oorschot AV and Narayanan R: Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci USA 91: 5957-5961, 1994.
36. Barton CM and Lemoine NR: Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression. Br J Cancer 71: 429-437, 1995.
37. Chen J, Wu X, Lin J and Levine AJ: Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 16: 2445-2453, 1996.
38. Haupt Y, Barak Y and Oren M: Cell type-specific inhibition of p53-mediated apoptosis by Mdm2. EMBO J 15: 1596-1606, 1996.
39. Teoh G, Urashima M, Ogata A, Chauhan D, DeCaprio JA, Treon SP, Schlossman RL and Anderson KC: Mdm2 protein overexpression promotes proliferation and survival of multiple myeloma cells. Blood 5: 1982-1992, 1997.
40. Kondo S, Barnett GH, Hara H, Morimura T and Takeuchi J: Mdm2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene 10: 2001-2006, 1995.
41. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994.